Insomnia Market - Size, Share, and Forecast [2021-2031]
The Insomnia Market is expected to register a CAGR of 4.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented based on Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies). The global analysis is further broken down at the regional level and major countries. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Insomnia Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Insomnia Market Segmentation
Drug Class- Antidepressants
- Melatonin Antagonist
- Benzodiazepines
- Nonbenzodiazepines
- Orexin Antagonist
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Strategic Insights
Insomnia Market Growth Drivers- Rising Prevalence of Sleep Disorders: Increase in prevalence of insomnia and other sleep disorders globally.
- Growing Geriatric Population: Aging population is more susceptible to sleep disturbances.
- Increased Stress Levels: Modern lifestyle with its associated stressors contributes to insomnia.
- Focus on Non-Pharmacological Treatments: Growing interest in non-drug therapies like cognitive behavioral therapy (CBT) for insomnia (CBT-I).
- Personalized Medicine: Tailoring treatment plans based on individual sleep patterns and underlying causes.
- Digital Therapeutics: Use of mobile apps and wearable devices for sleep tracking, relaxation techniques, and personalized feedback.
- Development of Novel Therapeutics: Research and development of new medications with improved efficacy and fewer side effects.
- Expansion of Telehealth Services: Providing access to sleep specialists and therapists through remote consultations.
- Integration of Sleep Technology: Developing innovative sleep-tracking devices and smart home technologies to improve sleep quality.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Insomnia Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Insomnia Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Insomnia Market is expected to grow at a CAGR of 4.5% between 2023-2031
The driving factors impacting the Insomnia Market are: Rising Prevalence of Sleep Disorders, Growing Geriatric Population and Increased Stress Levels
The future trends of the Insomnia Market are: Focus on Non-Pharmacological Treatments, Personalized Medicine and Digital Therapeutics
The leading players are: Mallinckrodt, Eisai Co., Ltd., Merck Sharp & Dohme Corp. (Merck & Co., Inc), Galt Pharmaceuticals, LLC., Pfizer Inc., Sanofi, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Insomnia Market - By Drug Class
1.3.2 Insomnia Market - By Distribution Channel
1.3.3 Insomnia Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INSOMNIA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INSOMNIA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INSOMNIA MARKET - GLOBAL MARKET ANALYSIS
6.1. INSOMNIA - GLOBAL MARKET OVERVIEW
6.2. INSOMNIA - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INSOMNIA MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIDEPRESSANTS
7.3.1. Overview
7.3.2. Antidepressants Market Forecast and Analysis
7.4. MELATONIN ANTAGONIST
7.4.1. Overview
7.4.2. Melatonin Antagonist Market Forecast and Analysis
7.5. BENZODIAZEPINES
7.5.1. Overview
7.5.2. Benzodiazepines Market Forecast and Analysis
7.6. NONBENZODIAZEPINES
7.6.1. Overview
7.6.2. Nonbenzodiazepines Market Forecast and Analysis
7.7. OREXIN ANTAGONIST
7.7.1. Overview
7.7.2. Orexin Antagonist Market Forecast and Analysis
8. INSOMNIA MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. ONLINE PHARMACIES
8.6.1. Overview
8.6.2. Online Pharmacies Market Forecast and Analysis
9. INSOMNIA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Insomnia Market Overview
9.1.2 North America Insomnia Market Forecasts and Analysis
9.1.3 North America Insomnia Market Forecasts and Analysis - By Drug Class
9.1.4 North America Insomnia Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Insomnia Market Forecasts and Analysis - By Countries
9.1.5.1 United States Insomnia Market
9.1.5.1.1 United States Insomnia Market by Drug Class
9.1.5.1.2 United States Insomnia Market by Distribution Channel
9.1.5.2 Canada Insomnia Market
9.1.5.2.1 Canada Insomnia Market by Drug Class
9.1.5.2.2 Canada Insomnia Market by Distribution Channel
9.1.5.3 Mexico Insomnia Market
9.1.5.3.1 Mexico Insomnia Market by Drug Class
9.1.5.3.2 Mexico Insomnia Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Insomnia Market Overview
9.2.2 Europe Insomnia Market Forecasts and Analysis
9.2.3 Europe Insomnia Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Insomnia Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Insomnia Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Insomnia Market
9.2.5.1.1 Germany Insomnia Market by Drug Class
9.2.5.1.2 Germany Insomnia Market by Distribution Channel
9.2.5.2 France Insomnia Market
9.2.5.2.1 France Insomnia Market by Drug Class
9.2.5.2.2 France Insomnia Market by Distribution Channel
9.2.5.3 Italy Insomnia Market
9.2.5.3.1 Italy Insomnia Market by Drug Class
9.2.5.3.2 Italy Insomnia Market by Distribution Channel
9.2.5.4 Spain Insomnia Market
9.2.5.4.1 Spain Insomnia Market by Drug Class
9.2.5.4.2 Spain Insomnia Market by Distribution Channel
9.2.5.5 United Kingdom Insomnia Market
9.2.5.5.1 United Kingdom Insomnia Market by Drug Class
9.2.5.5.2 United Kingdom Insomnia Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Insomnia Market Overview
9.3.2 Asia-Pacific Insomnia Market Forecasts and Analysis
9.3.3 Asia-Pacific Insomnia Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Insomnia Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Insomnia Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Insomnia Market
9.3.5.1.1 Australia Insomnia Market by Drug Class
9.3.5.1.2 Australia Insomnia Market by Distribution Channel
9.3.5.2 China Insomnia Market
9.3.5.2.1 China Insomnia Market by Drug Class
9.3.5.2.2 China Insomnia Market by Distribution Channel
9.3.5.3 India Insomnia Market
9.3.5.3.1 India Insomnia Market by Drug Class
9.3.5.3.2 India Insomnia Market by Distribution Channel
9.3.5.4 Japan Insomnia Market
9.3.5.4.1 Japan Insomnia Market by Drug Class
9.3.5.4.2 Japan Insomnia Market by Distribution Channel
9.3.5.5 South Korea Insomnia Market
9.3.5.5.1 South Korea Insomnia Market by Drug Class
9.3.5.5.2 South Korea Insomnia Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Insomnia Market Overview
9.4.2 Middle East and Africa Insomnia Market Forecasts and Analysis
9.4.3 Middle East and Africa Insomnia Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Insomnia Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Insomnia Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Insomnia Market
9.4.5.1.1 South Africa Insomnia Market by Drug Class
9.4.5.1.2 South Africa Insomnia Market by Distribution Channel
9.4.5.2 Saudi Arabia Insomnia Market
9.4.5.2.1 Saudi Arabia Insomnia Market by Drug Class
9.4.5.2.2 Saudi Arabia Insomnia Market by Distribution Channel
9.4.5.3 U.A.E Insomnia Market
9.4.5.3.1 U.A.E Insomnia Market by Drug Class
9.4.5.3.2 U.A.E Insomnia Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Insomnia Market Overview
9.5.2 South and Central America Insomnia Market Forecasts and Analysis
9.5.3 South and Central America Insomnia Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Insomnia Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Insomnia Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Insomnia Market
9.5.5.1.1 Brazil Insomnia Market by Drug Class
9.5.5.1.2 Brazil Insomnia Market by Distribution Channel
9.5.5.2 Argentina Insomnia Market
9.5.5.2.1 Argentina Insomnia Market by Drug Class
9.5.5.2.2 Argentina Insomnia Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. INSOMNIA MARKET, KEY COMPANY PROFILES
11.1. MALLINCKRODT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EISAI CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK SHARP AND DOHME CORP. (MERCK AND CO., INC)
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GALT PHARMACEUTICALS, LLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. PFIZER INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SANOFI
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SUMITOMO DAINIPPON PHARMA CO., LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VANDA PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Mallinckrodt
2. Eisai Co., Ltd.
3. Merck Sharp & Dohme Corp. (Merck & Co., Inc)
4. Galt Pharmaceuticals, LLC.
5. Pfizer Inc.
6. Sanofi
7. Sumitomo Dainippon Pharma Co., Ltd.
8. Takeda Pharmaceutical Company Limited
9. Teva Pharmaceutical Industries Ltd.
10. Vanda Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For